sinapinic acid has been researched along with Alloxan Diabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Estrada-Soto, S; Hernández-Luis, F; Hernández-Vázquez, E; Ramírez-Espinosa, JJ; Salgado-Barrera, S | 1 |
| Altındağ, F; Özdek, U | 1 |
| Abdelrahman, IA; Ahad, A; Ahmad, A; Al-Jenoobi, FI; Alkharfy, KM; Ansari, MA; Bin Jardan, YA; Raish, M; Shahid, M | 1 |
| Altindag, F; Colcimen, N | 1 |
| Kaltalioglu, K | 1 |
| Altındağ, F; Elasan, S; Ismael Alhalboosi, JK; Koyun, N; Özdek, U; Rağbetli, MÇ | 1 |
| Fan, Y; Geng, J; Han, Y; Pei, X; Qiu, H; Tian, H | 1 |
| Cheng, JT; Cherng, YG; Chung, HH; Kuo, SC; Lai, YW; Tsai, CC | 1 |
8 other study(ies) available for sinapinic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Synthesis and molecular docking of N'-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Halogenation; Hydrazines; Hypoglycemic Agents; Male; Molecular Docking Simulation; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2016 |
Synergistic effects of sinapic acid and ellagic acid ameliorate streptozotocin-induced diabetic nephropathy by inhibiting apoptosis, DNA damage, and structural deterioration in rats.
Topics: Animals; Apoptosis; Coumaric Acids; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Damage; Ellagic Acid; Female; Kidney; Rats; Rats, Wistar | 2021 |
Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
Topics: Animals; Apoptosis; Cardiotonic Agents; Coumaric Acids; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Heme Oxygenase (Decyclizing); Hyperglycemia; Inflammation; Male; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Streptozocin | 2022 |
Evaluation of the effects of sinapic acid and ellagic acid on sciatic nerve in experimental diabetic rats by immunohistochemical and stereological methods.
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Ellagic Acid; Laminin; Rats; Rats, Wistar; Sciatic Nerve; Streptozocin | 2023 |
Sinapic acid-loaded gel accelerates diabetic wound healing process by promoting re-epithelialization and attenuating oxidative stress in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Gels; Oxidative Stress; Rats; Re-Epithelialization; Skin; Wound Healing | 2023 |
Combined treatment of sinapic acid and ellagic acid attenuates hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Animals; Body Weight; Coumaric Acids; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Ellagic Acid; Female; Hyperglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Rats; Rats, Wistar; Streptozocin | 2021 |
Low-dose Sinapic Acid Abates the Pyroptosis of Macrophages by Downregulation of lncRNA-MALAT1 in Rats With Diabetic Atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biomarkers; Blood Glucose; Cells, Cultured; Coumaric Acids; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Down-Regulation; Hypoglycemic Agents; Inflammation Mediators; Macrophages; Male; Pyroptosis; Rats, Sprague-Dawley; RNA, Long Noncoding; Signal Transduction | 2018 |
Antihyperglycemic action of sinapic acid in diabetic rats.
Topics: Animals; Blood Glucose; Coumaric Acids; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Male; Monosaccharide Transport Proteins; Rats; Rats, Wistar | 2013 |